 |
BioVaxys
Last updated: October 11, 2024
Founders: Kenneth Kovan, David Berd
USA | Funding: $9.9M (+)
Website: https://biovaxys.com/
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma and ovarian cancer.
Website: https://biovaxys.com/
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma and ovarian cancer.
